TRICARE GLP-1 Coverage for Weight Loss (2026)
If you have TRICARE, the answer to “will it cover a GLP-1 for weight loss?” depends first on which TRICARE plan you are in. TRICARE Prime and TRICARE Select can cover Wegovy or Zepbound for weight management if you meet the prior authorization criteria. TRICARE For Life does not cover weight loss drugs at all.
Here is what TRICARE’s own pages and its pharmacy contractor’s documents say as of 2026-10-16, and how to find out where you stand.
Transformation Health is an independent guide, not a provider, and is not affiliated with TRICARE, the Department of Defense, the Defense Health Agency, or Express Scripts: we do not prescribe, sell medication, or work with insurance. This content is for general education and is not medical advice. Talk with a licensed provider about your situation.
The short answer
TRICARE is the Department of Defense health program, run by the Defense Health Agency. Express Scripts runs the TRICARE pharmacy program, and regional contractors handle medical benefits: Humana Military in the East Region, TriWest Healthcare Alliance in the West Region, and WPS Government Services for TRICARE For Life.[1]
As of 2026-10-16, tricare.mil says TRICARE may cover prescription weight loss drugs when medically necessary for some beneficiaries, and that you must meet certain requirements and get prior authorization. It also says TRICARE does not cover weight loss drugs for TRICARE For Life beneficiaries.[1]
| Who you are | Weight loss GLP-1 coverage (as of 2026-10-16) |
|---|---|
| Enrolled in a TRICARE Prime plan (including active duty service members in Prime, TRICARE Prime Remote, TRICARE Young Adult-Prime, and the Uniformed Services Family Health Plan) | Can be covered with prior authorization and a prescription from a TRICARE network provider[1][2] |
| Enrolled in a TRICARE Select plan (including TRICARE Reserve Select, TRICARE Retired Reserve, TRICARE Young Adult-Select, and the Continued Health Care Benefit Program) | Can be covered with prior authorization and a prescription from a TRICARE network provider[1][2] |
| TRICARE For Life (Medicare-eligible beneficiaries) | Not covered for weight loss[1][4] |
| Not enrolled in Prime, Select, or another premium-based plan (for example, direct care only or TRICARE Plus) | Prior authorizations for obesity medications became invalid on August 31, 2025[4] |
| Any plan, prescribed for type 2 diabetes | Certain GLP-1s, such as Ozempic and Mounjaro, are covered for diabetes when prior authorization criteria are met[4] |
Within Prime and Select, the TRICARE Formulary Search tool lists Wegovy, Zepbound, and Foundayo (orforglipron) as covered with limitations, with prior authorization required. It lists Saxenda (liraglutide) as non-formulary, also with prior authorization required.[3]
What the prior authorization form asks for
Express Scripts publishes one TRICARE prior authorization form for Wegovy (injection and tablets) and Zepbound. The version linked from the Formulary Search tool on 2026-10-16 is dated September 9, 2026.[2] Your prescriber completes it. Here are the main criteria for a first approval.
| Criterion | What the form says (as of 2026-10-16) |
|---|---|
| Plan | Enrolled in TRICARE Prime or TRICARE Select; other TRICARE plans are not approved[2] |
| Prescriber | A military hospital or clinic (MTF) provider or a TRICARE network provider who has billed TRICARE for the visit to assess you and develop a treatment plan[2] |
| Uses covered | Weight management, or (Zepbound only) moderate to severe obstructive sleep apnea in adults with obesity; other diagnoses are not approved[2] |
| Adult BMI | 30 or higher, or 27 to 29 with at least one weight-related condition[2] |
| Weight-related conditions listed | Diabetes or impaired glucose tolerance, obstructive sleep apnea, osteoarthritis, metabolic syndrome, high cholesterol (dyslipidemia), high blood pressure, MASH (a type of fatty liver disease), and established cardiovascular disease with a history of stroke, heart attack, or peripheral artery disease[2] |
| Lifestyle history | At least 6 months of behavior change and diet efforts without reaching the desired weight loss, continued during treatment, and documented in your medical record[2] |
| Older medication step | A 3-month trial of generic phentermine, benzphetamine, diethylpropion, or phendimetrazine without a 5 percent weight loss; or a contraindication to them; or an adverse reaction not expected with the requested drug; or at least 5 percent loss on one of them with BMI still high[2] |
| Ages 12 to 17 | Wegovy injection only, with BMI at or above the 95th percentile for age and sex and 6 months of documented lifestyle efforts[2] |
| Not approved if | Pregnant, using another GLP-1 medication at the same time, or a personal or family history of medullary thyroid cancer or MEN 2[2] |
| Approval length | 12 months; annual renewal required[2] |
| Renewal | Still engaged in behavior change and a reduced-calorie diet, plus at least 5 percent loss of baseline body weight after full dose titration for adults (at least 4 percent for ages 12 to 17), or improvement in apnea-hypopnea index for the sleep apnea pathway[2] |
Two items catch people most often.
The prescriber rule. The form asks whether the prescriber is an MTF or TRICARE network provider who has billed TRICARE for the visit. A prescription from a provider outside the TRICARE network, such as many cash-pay telehealth programs, does not meet that requirement.[2] If you want TRICARE to pay, start with your primary care manager or a network provider.
The older medication step. For weight management, the form asks about a 3-month trial of an older generic weight loss medication, or a documented reason you cannot take one, such as heart disease or high blood pressure that is not controlled on 2 or more medications.[2] The sleep apnea pathway for Zepbound does not include this step.
Active duty service members. The form says requests for active duty members must still go to Express Scripts first, even if they will not be approved under the form, and that reconsideration is then possible at the appropriate military hospital or clinic. Each military department also has its own policies on weight loss program participation for active duty members.[2] Ask your military treatment facility how this works for you.
Our guide to GLP-1 prior authorization covers how to prepare documentation, and most of it applies to the TRICARE process.
TRICARE For Life and weight loss drugs
TRICARE For Life is Medicare wraparound coverage for TRICARE beneficiaries who have Medicare. In a Q&A dated September 8, 2025, the Defense Health Agency said federal law does not authorize TRICARE For Life to cover weight loss medications when they are prescribed for weight loss as the sole or major condition, regardless of age. It said Express Scripts mailed notification letters on July 31, 2025, and that prior authorizations for obesity medications became invalid on August 31, 2025 for TRICARE For Life beneficiaries.[4]
The same Q&A answers why TRICARE For Life does not follow Medicare’s exceptions for sleep apnea and heart disease: TRICARE and Medicare operate under different laws, and the laws for TRICARE For Life exclude medications intended to control or reduce weight even when other conditions are present.[4] Diabetes is different. The Q&A says TRICARE covers certain GLP-1s for type 2 diabetes, including Ozempic, Trulicity, Mounjaro, and Victoza, for patients with a diabetes diagnosis who meet the prior authorization criteria, regardless of health plan.[4]
If you have TRICARE For Life, check Medicare Part D. As of 2026-10-16, tricare.mil says that beginning July 1, 2026, Medicare Part D covers certain weight loss drugs under the Medicare GLP-1 Bridge, and it points beneficiaries without Part D to information on when they can enroll.[1] CMS runs the Bridge from July 1, 2026 through December 31, 2027 for eligible Part D enrollees.[5] Federal law lets Part D exclude drugs used for weight loss, but Part D plans can cover a GLP-1 for another FDA-approved use, such as Wegovy for reducing cardiovascular risk or Zepbound for obstructive sleep apnea in adults with obesity.[4][6][7] Our pages on Medicare Part D and GLP-1 coverage and the Medicare GLP-1 Bridge cover the details.
TRICARE, VA health care, and CHAMPVA are different programs
These names get mixed up, and the drug rules differ by program. TRICARE is the Defense Department’s program for service members, retirees, and their families. VA health care is for eligible veterans enrolled with the VA, and it uses its own national formulary and criteria. CHAMPVA is a separate VA program for certain spouses, dependents, and survivors of veterans, and people eligible for TRICARE cannot get CHAMPVA.[8] If you use the VA, see our page on VA GLP-1 coverage.
How to check your own coverage
Confirm your plan. Prime and Select can cover weight management GLP-1s with prior authorization. TRICARE For Life does not cover them for weight loss. Your enrollment information shows which plan you have.
Look up the drug. The TRICARE Formulary Search tool shows coverage status, prior authorization requirements, the current prior authorization form, and your cost by beneficiary type and fill location (military pharmacy, home delivery, or retail network pharmacy).[3] tricare.mil says your costs depend on who you are, the drug category, and where you fill your prescription.[1]
Contact Express Scripts or your regional contractor. For pharmacy coverage questions, tricare.mil says to contact Express Scripts.[1] For medical benefits and network provider questions, contact your regional contractor (Humana Military in the East, TriWest Healthcare Alliance in the West), or WPS Government Services for TRICARE For Life. Contact details for each are listed on tricare.mil.
Talk with your provider about your record. Before a request goes in, ask whether your chart documents your BMI, any weight-related conditions, 6 months of lifestyle efforts, and your history with older weight loss medications. Filling gaps first is usually faster than appealing a denial later.
If the answer is no
What you do next depends on the reason.
A criterion was not met (Prime or Select). Ask your prescriber which item was missing and whether a new request makes sense once it is addressed. If you believe you met the criteria, ask Express Scripts how to request reconsideration or appeal. The general tips in our guide on what to do when a GLP-1 is denied can help you prepare.
You have TRICARE For Life. There is no prior authorization path for weight loss drugs under TRICARE For Life.[4] Check whether Medicare Part D or the Medicare GLP-1 Bridge applies to you, as described above.
You want to look outside TRICARE. Options include:
- Other coverage you have. An employer plan, a spouse’s plan, or Medicare may have different rules. Call the member services number on that card.
- Manufacturer savings and self-pay options. Novo Nordisk and Eli Lilly each publish savings and self-pay terms, and the terms change. Our page on GLP-1 savings programs compares them.
- Cash-pay telehealth programs. Some prescribe brand-name medications and some prescribe compounded medications. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.[9] Our page on compounded GLP-1 without insurance explains how that route works.
Prices vary by program, medication, and dose. Compare the total cost: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms. At most telehealth programs, a licensed provider reviews your health history and decides whether a prescription is appropriate. If you get medication outside TRICARE, tell your primary care manager so your records stay complete. The full insurance coverage overview can help you weigh the options side by side.
Transformation Health does not accept payment from providers. How we make money.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedCitations
[1] TRICARE, Defense Health Agency. “Prescription Weight Loss Drugs.” Last updated 10/1/2026 (includes the tricare.mil login menu listing regional and pharmacy contractors). Accessed 2026-10-16. https://www.tricare.mil/CoveredServices/IsItCovered/WeightLossDrugs
[2] Express Scripts, TRICARE pharmacy program contractor. “TRICARE Prior Authorization Request Form for semaglutide injection/tablets (Wegovy), tirzepatide injection (Zepbound Pen Injector).” Dated September 9, 2026. Retrieved from the TRICARE Formulary Search tool. Accessed 2026-10-16. https://www.express-scripts.com/interaction/member-proxinator/1/member/v1/drugpricing/prelogin/fst/drug/forms/content?repository=EIS_P8_DC%3AesiCPS&documentId=%7B509D82A0-0000-CD13-9176-179F9817FEDB%7D
[3] Express Scripts. TRICARE Formulary Search tool, entries for Wegovy, Zepbound, Foundayo, Saxenda, Ozempic, and Mounjaro. Accessed 2026-10-16. https://www.express-scripts.com/frontend/open-enrollment/tricare/fst/
[4] Defense Health Agency. “Q&A: TRICARE For Life Coverage of Weight Loss Medications.” September 8, 2025. Published on TRICARE Newsroom and republished by My Air Force Benefits (U.S. Air Force). Accessed 2026-10-16. https://myairforcebenefits.us.af.mil/QandA-TRICARE-For-Life-Coverage-of-Weight-Loss-Medications
[5] Centers for Medicare and Medicaid Services. “Medicare GLP-1 Bridge.” Accessed 2026-10-16. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
[6] Novo Nordisk. WEGOVY (semaglutide) prescribing information. Revised 06/2026. Accessed 2026-10-16. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf
[7] Eli Lilly and Company. ZEPBOUND (tirzepatide) prescribing information. Revised 08/2026. Accessed 2026-10-16. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf
[8] U.S. Department of Veterans Affairs. “CHAMPVA benefits.” Accessed 2026-10-16. https://www.va.gov/family-and-caregiver-benefits/health-and-disability/champva/
[9] U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” Accessed 2026-10-16. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Important disclosures
Coverage information on this page is current as of 2026-10-16, is general and educational, and changes frequently. TRICARE prior authorization forms are revised over time. This page does not represent a determination about your eligibility or benefits and is not legal advice. Confirm current coverage, criteria, and costs with Express Scripts, your regional contractor, or tricare.mil.
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. A licensed provider decides whether a prescription is appropriate. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency. Wegovy, Ozempic, Saxenda, and Victoza are trademarks of Novo Nordisk A/S. Zepbound, Mounjaro, Trulicity, and Foundayo are trademarks of Eli Lilly and Company. TRICARE is a registered trademark of the Department of Defense, Defense Health Agency. Express Scripts, Humana Military, TriWest Healthcare Alliance, WPS Government Services, and CHAMPVA are marks of their respective owners. Transformation Health is not affiliated with or endorsed by the Department of Defense, the Defense Health Agency, TRICARE, Express Scripts, Novo Nordisk, or Eli Lilly. Transformation Health does not accept payment from providers. How we make money.